HSPA9 Gene

HSPA9 Gene

Introduction

Hspa9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

HSPA9 Gene

Introduction

Hspa9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Heat Shock Protein Family A (Hsp70) Member 9 is encoded by the HSPA9 gene located on chromosome 5q31.2. This gene encodes mortalin, a mitochondrial Hsp70 family member essential for mitochondrial protein import, folding, and quality control. Mortalin is a multi-functional protein involved in mitochondrial biogenesis, cellular metabolism, stress response, and aging. HSPA9 is increasingly recognized as a Parkinson's disease susceptibility gene, with decreased expression observed in PD brains. [@uniprot]

Gene Information

<div class="infobox infobox-gene"> [@burbulla2010]
<table> [@liu2005]
<tr><th>Gene Symbol</th><td>HSPA9</td></tr>
<tr><th>Full Name</th><td>Heat Shock Protein Family A (Hsp70) Member 9 (Mortalin)</td></tr>
<tr><th>Chromosome</th><td>5q31.2</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/3313" target="_blank">3313</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/604736" target="_blank">604736</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://ensembl.org/Homo_species/Gene/Summary?g=ENSG00000113014" target="_blank">ENSG00000113014</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P38646" target="_blank">P38646</a></td></tr>
<tr><th>Protein Length</th><td>679 amino acids</td></tr>
<tr><th>Molecular Weight</th><td>73.6 kDa</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">80 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Domains

HSPA9/Mortalin has a mitochondrial Hsp70 domain structure:

• N-terminal ATPase domain (1-400): Binds and hydrolyzes ATP, regulates substrate binding
• Substrate-binding domain (400-550): C-terminal peptide-binding domain
• C-terminal domain (550-679): Regulatory elements and mitochondrial targeting sequence

Molecular Function

Mortalin performs essential mitochondrial functions:

Expression Pattern

HSPA9/Mortalin exhibits broad expression:

• Brain: High expression in [neurons](/entities/neurons), especially dopaminergic neurons
• Heart: High expression in cardiac muscle
• Liver: High expression in hepatocytes
• Pancreas: High expression in beta cells
• Tissue culture: Ubiquitously expressed in most cell lines

Disease Associations

| Disease | Mechanism | Evidence |
|---------|-----------|----------|
| Parkinson's Disease | Reduced mortalin in SNpc; mitochondrial dysfunction | Human brain studies |
| Wolfram Syndrome | WFS1 interactor; diabetes mellitus | Genetic studies |
| Cancer | Elevated in many tumors; anti-apoptotic | Tumor expression |
| Aging | Declines with age; cellular senescence | Age-related studies |
| ALS | Mitochondrial dysfunction in motor neurons | Patient studies |

Role in Neurodegeneration

HSPA9/Mortalin in Parkinson's disease:

Therapeutic Implications

HSPA9/Mortalin as a therapeutic target:

• Gene therapy: AAV-mediated HSPA9 delivery to dopaminergic neurons
• Small molecule inducers: Upregulate mortalin expression
• Mitochondrial protectants: Protect against mitochondrial toxins
• Anti-aging: Mortalin-based interventions for age-related neurodegeneration

Animal Models

HSPA9 knockout is embryonic lethal:

• Severe developmental defects
• Mitochondrial dysfunction
• Conditional knockouts show dopaminergic neuron loss
• Increased sensitivity to mitochondrial toxins

Research Directions

• Mortalin-p53 interactions in neurodegeneration
• Mitochondrial protein import machinery
• HSPA9 in dopaminergic neuron survival
• Development of mortalin modulators

Background

The study of Hspa9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Genes Overview](/genes)
• [Hsp70 Family Proteins](/content/proteins)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [Heat Shock Response Pathway](/brain-regions/pons)

External Links

• [NCBI Gene: HSPA9](https://www.ncbi.nlm.nih.gov/gene/3313)
• [UniProt: HSPA9/Mortalin](https://www.uniprot.org/uniprot/P38646)
• [Ensembl: HSPA9](https://ensembl.org/Homo_species/Gene/Summary?g=ENSG00000113014)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving HSPA9 Gene discovered through SciDEX knowledge graph analysis: